Corcept Therapeutics reported $801.72M in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Acadia Pharmaceuticals USD 1.23B 93.19M Jun/2025
Alaunos Therapeutics USD 2.76M 795K Dec/2024
ANI Pharmaceuticals USD 1.34B 50.57M Jun/2025
Ardelyx USD 466.77M 31.02M Jun/2025
Aurora Cannabis CAD 837.84M 28.68M Jun/2025
BioMarin Pharmaceutical USD 7.46B 309.33M Jun/2025
Bristol-Myers Squibb USD 94.68B 2.25B Jun/2025
Canopy Growth CAD 904.67M 259.55M Jun/2025
Corcept Therapeutics USD 801.72M 44.73M Jun/2025
Eli Lilly USD 100.92B 11.53B Jun/2025
J&J USD 193.67B 13.57B Mar/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Merck USD 117.52B 2.4B Jun/2025
Novartis USD 104.4B 4.45B Jun/2025
Novartis USD 104.4B 2.15B Jun/2025
Pacira USD 1.54B 49.41M Jun/2025
Pfizer USD 206.1B 1.93B Jun/2025
Supernus Pharmaceuticals USD 1.38B 35.11M Jun/2025
TG Therapeutics USD 702.61M 45.92M Jun/2025